A novel MYO6 splice site mutation causes autosomal dominant sensorineural hearing loss type DFNA22 with a favourable outcome after cochlear implantation

Audiol Neurootol. 2013;18(3):192-9. doi: 10.1159/000350246. Epub 2013 Apr 26.

Abstract

Mutations in MYO6 encoding an atypical myosin motor protein important for inner ear hair cell function have been associated with autosomal recessive (DFNB37) and autosomal dominant (DFNA22) types of hearing loss in a few families worldwide. After genome-wide linkage analysis, we identified a novel MYO6 mutation at the splice acceptor site of exon 7 (c.554-1G>A) in an extended German family with autosomal dominant postlingual non-syndromic hearing impairment. Analysis of blood-derived cDNA revealed different aberrantly spliced mRNAs caused by the mutation, which are predicted to severely interfere with protein function. Two of the family members underwent cochlear implantation at ages 53 and 65. Here, we present detailed clinical data of this family which suggest a favourable outcome of cochlear implantation in hearing-impaired individuals with a MYO6 mutation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cochlear Implantation*
  • Female
  • Genetic Linkage
  • Genotype
  • Germany
  • Haplotypes
  • Hearing Loss, Sensorineural / genetics*
  • Hearing Loss, Sensorineural / surgery
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Myosin Heavy Chains / genetics*
  • Pedigree
  • RNA Splice Sites
  • Treatment Outcome

Substances

  • RNA Splice Sites
  • myosin VI
  • Myosin Heavy Chains

Supplementary concepts

  • Deafness, autosomal dominant nonsyndromic sensorineural 22